AVENUE THERAPEUTICS
Avenue Therapeutics is a New York-based, specialty pharmaceutical company founded in 2015. The company is a majority-controlled subsidiary of Fortress Biotech, Inc., a biopharmaceutical company focused on acquiring, developing, and commercializing novel pharmaceutical and biotechnology products.
AVENUE THERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2015-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.avenuetx.com
Total Employee:
1+
Status:
Active
Contact:
781-652-4500
Email Addresses:
[email protected]
Total Funding:
19.6 M USD
Technology used in webpage:
Euro Apple Mobile Web Clips Icon Amazon HSTS CloudFront PostalAddress Schema COVID-19 Amazon Sydney Region Corporation Schema
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Nutcracker Therapeutics
Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.
Current Employees Featured
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-11-08 | Baergic Bio | Baergic Bio acquired by Avenue Therapeutics | N/A |
Official Site Inspections
http://www.avenuetx.com Semrush global rank: 12.97 M Semrush visits lastest month: 78
- Host name: cust-155.130.138.21.switch.com
- IP address: 155.130.138.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Avenue Therapeutics"
Avenue Therapeutics, Inc. (ATXI)
Nov 14, 2024 For more information, visit www.avenuetx.com. View Management Team View Board of Directors. Stock Information. IR Contacts. Headquarters. Avenue Therapeutics, Inc. 1111 Kane Concourse Suite 301 …See details»
Company Information :: Avenue Therapeutics, Inc. (ATXI)
For more information, visit www.avenuetx.com. Latest Presentation. Investor Presentation View This Presentation. Contact Information. Investor Relations Jaclyn Jaffe T: 781-652-4500 [email protected]. Company Contact Avenue …See details»
Investors | Avenue Therapeutics
Investors. Avenue Therapeutics, Inc., a Fortress Biotech Company, is a specialty pharmaceutical company that acquires or in-licenses, develops and commercializes products for use in acute healthcare or hospital settings.See details»
P118413 ATXI - Corporate Presentation - avenuetx.com
National Organization of Rare Disease, “Kennedy’s Disease,” 2022. 2. M. Zanovello et al., Oxford University Press on behalf of the Guarantors of Brain. 2023. Based on U.S. male population of …See details»
Avenue Therapeutics - Crunchbase Company Profile & Funding
Organization. Avenue Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Contact Email …See details»
Corporate Governance :: Avenue Therapeutics, Inc. (ATXI)
Mr. Oltmans joined our Board of Directors in April 2021. Mr. Oltmans, 57, is currently General Counsel of Fulcrum Therapeutics, Inc. and has over 25 years of experience in corporate law …See details»
Avenue Therapeutics - LinkedIn
Avenue Therapeutics | 1,263 followers on LinkedIn. Avenue Therapeutics, Inc. (NASDAQ: ATXI), a Fortress Biotech (NASDAQ: FBIO) Company, is a specialty pharmaceutical company. …See details»
Avenue Therapeutics - businessabc.net
Nov 14, 2024 Avenue Therapeutics was founded in January 2015 to develop and commercialize intravenous (IV) tramadol, a novel non-opioid product candidate for managing moderate to …See details»
Avenue Therapeutics Reaches Final Agreement with the U.S. FDA …
Jan 4, 2024 UN predicts world economic growth at subdued 2.8% in 2025. The world economy resisted battering by conflicts and inflation last year and is expected to grow a subdued 2.8% …See details»
Avenue Therapeutics - Work in biotech
Avenue Therapeutics is seeking to develop and commercialize therapies to treat central nervous system (CNS) disorders. There is a large unmet patient and market need in the CNS …See details»
P117119_Avenue Therapeutics
3 Executive Summary Avenue Therapeutics is a specialty pharmaceutical company that seeks to develop and commercialize therapies to treat central nervous system (CNS) conditionsSee details»
Avenue Therapeutics Reports Third Quarter 2024 Financial Results …
Nov 14, 2024 Avenue is headquartered in Miami, FL and was founded by Fortress Biotech, Inc. (Nasdaq: FBIO). For more information, visit www.avenuetx.com. Forward-Looking Statements …See details»
Contacts :: Avenue Therapeutics, Inc. (ATXI)
VStock Transfer, LLC 18 Lafayette Place Woodmere, NY 11598 T: 212-828-8436 [email protected] https://www.vstocktransfer.comSee details»
Avenue Therapeutics Announces Appointment of Dr. Thomas G.
For more information, visit www.avenuetx.com. Forward-Looking Statements This press release may contain “forward-looking statements” within the meaning of Section 27A of the Securities …See details»
Avenue Therapeutics Reaches Final Agreement with the U.S.
Jan 4, 2024 For more information, visit www.avenuetx.com. Forward-Looking Statements This press release contains predictive or “forward-looking statements” within the meaning of the …See details»
Pipeline | Avenue Therapeutics
Press Alt+1 for screen-reader mode, Alt+0 to cancel. Use Website In a Screen-Reader Mode. Accessibility Screen-Reader Guide, Feedback, and Issue ReportingSee details»
Avenue Therapeutics to Participate in Maxim Group’s 2024 …
Oct 9, 2024 Avenue is headquartered in Miami, FL and was founded by Fortress Biotech, Inc. (Nasdaq: FBIO). For more information, visit www.avenuetx.com. Contact: Jaclyn Jaffe Avenue …See details»
Careers | Avenue Therapeutics
If you’re interested in submitting an application to Avenue Therapeutics, please send your resume to [email protected].. Beware of recruiting fraud. Learn moreSee details»
Avenue Therapeutics Reports Full Year 2023 Financial Results and …
Mar 18, 2024 For more information, visit www.avenuetx.com. Forward-Looking Statements This press release contains predictive or “forward-looking statements” within the meaning of the …See details»